- Home
- TRNR vs EVOK Comparison
TRNR vs EVOK Comparison
Compare TRNR & EVOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRNR
- EVOK
- Stock Information
- Founded
- TRNR 2017
- EVOK 2007
- Country
- TRNR United States
- EVOK United States
- Employees
- TRNR N/A
- EVOK N/A
- Industry
- TRNR Consumer Electronics/Appliances
- EVOK Biotechnology: Pharmaceutical Preparations
- Sector
- TRNR Technology
- EVOK Health Care
- Exchange
- TRNR Nasdaq
- EVOK Nasdaq
- Market Cap
- TRNR 3.9M
- EVOK 4.2M
- IPO Year
- TRNR 2023
- EVOK 2013
- Fundamental
- Price
- TRNR $0.95
- EVOK $2.15
- Analyst Decision
- TRNR
- EVOK
- Analyst Count
- TRNR 0
- EVOK 0
- Target Price
- TRNR N/A
- EVOK N/A
- AVG Volume (30 Days)
- TRNR 2.9M
- EVOK 20.9K
- Earning Date
- TRNR 05-19-2025
- EVOK 05-13-2025
- Dividend Yield
- TRNR N/A
- EVOK N/A
- EPS Growth
- TRNR N/A
- EVOK N/A
- EPS
- TRNR N/A
- EVOK N/A
- Revenue
- TRNR $5,380,000.00
- EVOK $10,249,415.00
- Revenue This Year
- TRNR $355.02
- EVOK $58.84
- Revenue Next Year
- TRNR N/A
- EVOK $58.11
- P/E Ratio
- TRNR N/A
- EVOK N/A
- Revenue Growth
- TRNR 459.25
- EVOK 97.84
- 52 Week Low
- TRNR $0.80
- EVOK $1.94
- 52 Week High
- TRNR $996.00
- EVOK $12.32
- Technical
- Relative Strength Index (RSI)
- TRNR 40.22
- EVOK 28.89
- Support Level
- TRNR $0.81
- EVOK $1.94
- Resistance Level
- TRNR $1.03
- EVOK $2.40
- Average True Range (ATR)
- TRNR 0.16
- EVOK 0.21
- MACD
- TRNR 0.02
- EVOK 0.04
- Stochastic Oscillator
- TRNR 31.91
- EVOK 24.14
About TRNR Interactive Strength Inc.
Interactive Strength Inc provides an integrated home fitness platform that allows its customers to participate in interactive wellness and strength-based training sessions. Its health coaching services encompass guidance and coaching on nutrition, recovery, sleep, and other health and lifestyle categories. The company generates revenue from sales of its connected fitness products, membership revenue, and personal training revenue.
About EVOK Evoke Pharma Inc.
Evoke Pharma Inc is a specialty pharmaceutical company focused on the development and commercialization of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa.